Girolamo Calo

Girolamo Calo publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Girolamo Calo sits on this spectrum.

Girolamo Calo D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Girolamo Calo sits on this spectrum.

Best Publications

• Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.

  Aaron A. Thompson;Wei-Wei Liu;Eugene Chun;Vsevolod Katritch

  585
  Citations

• THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors

  Stephen P.H. Alexander;Arthur Christopoulos;Anthony P. Davenport;Eamonn Kelly

  427
  Citations

• The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

  Unknown

  359
  Citations

• Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems

  Lawrence Toll;Michael R. Bruchas;Girolamo Calo;Brian M. Cox

  305
  Citations

• A new selective antagonist of the nociceptin receptor

  Remo Guerrini;Girolamo Calo;Anna Rizzi;Raffaella Bigoni

  279
  Citations

• Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.

  Remo Guerrini;Girolamo Calo;Anna Rizzi;Clementina Bianchi

  275
  Citations

• Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist

  Girolamo Calo;Remo Guerrini;Raffaella Bigoni;Anna Rizzi

  233
  Citations

• Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

  A Rizzi;R Vergura;G Marzola;C Ruzza

  207
  Citations

• [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

  Girolamo Calo;Anna Rizzi;Daniela Rizzi;Raffaella Bigoni

  202
  Citations

• Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile

  ND Dietis;R Guerrini;G Calo;s Salvadori

  202
  Citations

• Sudden death from pulmonary thromboembolism: chronobiological aspects.

  M. Gallerani;R. Manfredini;L. Ricci;E. Grandi

  159
  Citations

• The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.

  Girolamo Calò;Anna Rizzi;Giovanni Bogoni;Vitold Neugebauer

  152
  Citations

• Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.

  E. C. Gavioli;G. Marzola;R. Guerrini;R. Bertorelli

  146
  Citations

• Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.

  G Calò;A Rizzi;G Marzola;R Guerrini

  133
  Citations

• Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.

  Remo Guerrini;Severo Salvadori;Anna Rizzi;Domenico Regoli

  132
  Citations

• Anxiolytic-like effect of neuropeptide S in the rat defensive burying.

  Giovanni Vitale;Monica Filaferro;Valentina Ruggieri;Sonia Pennella

  130
  Citations

• Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice

  E. C. Gavioli;E. C. Gavioli;C. W. Vaughan;G. Marzola;R. Guerrini

  126
  Citations

• Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?

  Hanns Ulrich Zeilhofer;Girolamo Calò

  124
  Citations

• Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.

  Girolamo Calo;Remo Guerrini;Raffaella Bigoni;Anna Rizzi

  123
  Citations

• Cardiovascular Effects of Nociceptin in Unanesthetized Mice

  Paolo Roberto Madeddu;Maria Bonaria Salis;Anna Franca Milia;Costanza Emanueli

  123
  Citations